Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Pharmacomicrobiomics

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Pharmacomicrobiomics focuses on how interindividual variation in the human microbiome affects the pharmacokinetics and pharmacodynamics of drugs, including drug metabolism, bioavailability, efficacy, and adverse effects (1, 2, 3)

References:

(1) Torres-Carrillo et al. 2023 Int J Mol Sci 24(23): 17100
(2) Zhao et al. 2023 Signal Transduct Target Ther 8(1): 386
(3) Doestzada et al. 2018 Protein Cell 9(5): 432-45

References (Sources)

Drug-microbiota interactions: an emerging priority for precision medicine
Zhao et al. 2023 Signal Transduct Target Ther 8(1): 386
Review
Pharmacomicrobiomics and Drug-Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy
Torres-Carrillo et al. 2023 Int J Mol Sci 24(23): 17100
Review
Pharmacomicrobiomics: a novel route towards personalized medicine?
Doestzada et al. 2018 Protein Cell 9(5): 432-45
Review

AI Chat

5/29/2026

Chat with our artificial intelligence:

Start chat!